These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12993288)

  • 1. The clinical significance of aminoaciduria.
    BRICK IB
    N Engl J Med; 1952 Oct; 247(17):635-44. PubMed ID: 12993288
    [No Abstract]   [Full Text] [Related]  

  • 2. [Excretion of 17-ketosteroids in hepatolenticular degeneration].
    STARKA L; BLEHOVA B
    Endokrinologie; 1962 Jan; 42():1-7. PubMed ID: 13916326
    [No Abstract]   [Full Text] [Related]  

  • 3. The metabolic disorder in hepato-lenticular degeneration.
    MATTHEWS WB; MILNE MD; BELL M
    Q J Med; 1952 Oct; 21(84):425-46. PubMed ID: 13004260
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormalities of copper metabolism in Wilson's disease and their relationship to the aminoaciduria.
    BEARN AG; KUNKEL HG
    J Clin Invest; 1954 Mar; 33(3):400-9. PubMed ID: 13143088
    [No Abstract]   [Full Text] [Related]  

  • 5. On the determination of ethanolamine in urine and the factors affecting its daily output.
    LUCK JM; WILCOX A
    J Biol Chem; 1953 Dec; 205(2):859-66. PubMed ID: 13129264
    [No Abstract]   [Full Text] [Related]  

  • 6. DISTURBANCES OF COPPER AND AMINO ACID METABOLISM IN CLINICALLY HEALTHY RELATIVES OF PATIENTS WITH HEPATOLENTICULAR DEGENERATION.
    PATRUNOVA VP
    Fed Proc Transl Suppl; 1964; 23():340-2. PubMed ID: 14145670
    [No Abstract]   [Full Text] [Related]  

  • 7. Decreased urinary excretion of 2-aminoethanol by irradiated human beings.
    CAVALIERI RR; VAN METRE MT; SIVERTSEN WI
    Nature; 1961 Sep; 191():1303-4. PubMed ID: 13877446
    [No Abstract]   [Full Text] [Related]  

  • 8. Abnormal copper metabolism and hepatolenticular degeneration.
    DENNY-BROWN D
    Res Publ Assoc Res Nerv Ment Dis; 1953; 32():190-7. PubMed ID: 13134643
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of copper in serum and urine of hepatolenticular degeneration patient and their clinic meaning].
    Deng SL; Li XF; Guo XL
    Guang Pu Xue Yu Guang Pu Fen Xi; 2003 Jun; 23(3):576-8. PubMed ID: 12953546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The amino-acids and the polypeptides of urine].
    BOULANGER P; BISERTE G
    J Med Lyon; 1954 Jan; 35(817):55-63. PubMed ID: 13143362
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on copper metabolism. XIV. Radioactive copper studies in normal subjects and in patients with hepatolenticular degeneration.
    BUSH JA; MAHONEY JP; MARKOWITZ H; GUBLER CJ; CARTWRIGHT GE; WINTROBE MM
    J Clin Invest; 1955 Dec; 34(12):1766-78. PubMed ID: 13271562
    [No Abstract]   [Full Text] [Related]  

  • 12. The amino acid content of the blood and urine in Wilson's disease.
    STEIN WH; BEARN AG; MOORE S
    J Clin Invest; 1954 Mar; 33(3):410-9. PubMed ID: 13143089
    [No Abstract]   [Full Text] [Related]  

  • 13. [On methods of copper determination in body fluids in disorders of copper metabolism].
    Kamm G
    Arch Toxikol; 1969; 25(1):102-8. PubMed ID: 5806372
    [No Abstract]   [Full Text] [Related]  

  • 14. [2 CASES OF WILSON'S DISEASE, WITH SPECIAL REFERENCE TO THERAPY AND THE DANGER OF FURTHER PROGRESS OF THE DISEASE].
    SOTODA S; YAMAKI Y; MIYAKO M
    Chiryo; 1964; 46():643-7. PubMed ID: 14126932
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of Wilson's disease with 2,3-dimercaptopropanol].
    MALECI O; CECOTTO C
    Riv Neurol; 1953; 23(6):809-15. PubMed ID: 13168151
    [No Abstract]   [Full Text] [Related]  

  • 16. A modified Morson bladder retractor.
    FISHER OD; NEILL DW
    Lancet; 1955 Feb; 268(6859):334-5. PubMed ID: 13234374
    [No Abstract]   [Full Text] [Related]  

  • 17. Rickets and amino-aciduria.
    JONXIS JH; SMITH PA; HUISMAN TH
    Lancet; 1952 Nov; 2(6743):1015-7. PubMed ID: 12991687
    [No Abstract]   [Full Text] [Related]  

  • 18. Contribution to the data on copper concentration in blood and urine in patients with Wilson's disease and in normal subjects.
    Lech T; Sadlik JK
    Biol Trace Elem Res; 2007 Jul; 118(1):16-20. PubMed ID: 17848726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urine copper determination in Wilson's disease during therapy].
    Schnack H
    Wien Z Inn Med; 1967; 48(12):469-76. PubMed ID: 5620588
    [No Abstract]   [Full Text] [Related]  

  • 20. [IMPORTANCE OF CHROMATOGRAPHIC ANALYSIS OF THE URINE FOR THE DIAGNOSIS OF CONGENITAL METABOLISM DISORDERS].
    ORT M; KUCERA J; JANSA M
    Cesk Pediatr; 1964 Mar; 19():204-10. PubMed ID: 14142696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.